West Virginia Medicaid

Does West Virginia Medicaid cover Mounjaro?

Quick answer · Type 2 Diabetes

West Virginia Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.

  • Medicaid: Covered with requirements. A1C of 7% or higher

Last verified June 3, 2026. Policy effective January 1, 2026. Source: download. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What West Virginia Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered with requirements

What you need to qualify

  • A1C of 7% or higher
  • Prior trial of 3 other GLP-1 medications (Ozempic, Trulicity, and Victoza)
  • Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Non-preferred GLP-1 agonist — all criteria must be met

All of:

  • Diagnosis of Diabetes Mellitus Type II
  • Current A1C submitted and A1C >= 7%
  • Documentation of 90 days of compliance on all current diabetic therapies
  • Documentation of treatment failure with ALL unique preferred agents in the GLP-1 class (Ozempic, Trulicity, and Victoza)

Documentation to bring

  • Documentation of Diabetes Mellitus Type II diagnosis
  • Current A1C lab result (must be >= 7%)
  • Documentation demonstrating 90 days of compliance on all current diabetic therapies
  • Documentation of treatment failure with all preferred GLP-1 agents (Ozempic, Trulicity, Victoza)

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • To renew, the plan looks for improvement in A1C and Re-authorization requires documentation of continued compliance on all diabetic therapies AND A1C must reach goal (A1C <= 8% OR demonstrated continued improvement).

Not covered when

  • GLP-1 agents will NOT be approved in combination with a DPP-4 inhibitor
  • Type 1 diabetes

Policy note: Mounjaro (tirzepatide) is listed as a NON-PREFERRED agent in the GLP-1 Agonists class. Approvals are in 6-month intervals. Requires treatment failure with ALL three preferred agents: Ozempic, Trulicity, and Victoza. The class note explicitly prohibits concurrent use with a DPP-4 inhibitor.

Policy effective January 1, 2026 · verified June 3, 2026 · source: download

Why Mounjaro requests get denied by West Virginia Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
  2. No recent A1C result on file.
  3. Required prior medication trials not documented.

Frequently asked questions

Does West Virginia Medicaid cover Mounjaro?
West Virginia Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.
How long does a Mounjaro approval last with West Virginia Medicaid?
Initial approvals last 6 months, and renewals are granted in 6-month periods.
What does West Virginia Medicaid require to renew Mounjaro?
Improvement in A1C and Re-authorization requires documentation of continued compliance on all diabetic therapies AND A1C must reach goal (A1C <= 8% OR demonstrated continued improvement).
How current is this information?
This page reflects West Virginia Medicaid's written policy as of January 1, 2026, last verified against the source document on June 3, 2026.

Other medications under West Virginia Medicaid

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes West Virginia Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.